ADHD Slows Speech in Poor Hearing: Evidence from Eye Movements

Published Date: 02 Mar 2023

A new study by Prof. Boaz Ben-David and Rony Lemel of Reichman University's Baruch Ivcher School of Psychology has found that attention deficit hyperactivity disorder (ADHD) causes slow and difficult understanding of words.

Read Full News

Latest News

Physicians’ Online Health Advice: Who Should Be Watching?

Physicians can reach thousands through social media, raising questions about professional oversight and the consequences of unverified medical advice online.

An Ode to Primary Care

Dr George Lundberg writes his ode to primary care — and a warning that we’re letting it die.

Tetanus Is Still Around: Keep Vaccinations Up to Date

Dr Bryant explains that tetanus is not passed between individuals, it is caused by a species of bacteria found in the environment.

Has Point-of-Care Ultrasound Become the Stethoscope?

Point-of-care ultrasound promises rapid, bedside answers without expensive imaging referrals. But whether primary care is fully embracing the technology is up for debate.

Lipid Levels Modify Heart Disease Risk With Hormone Therapy

Menopausal hormone therapy is tied to a higher coronary heart disease risk in women with high LDL cholesterol levels on estrogen and medroxyprogesterone acetate but not in those with low LDL levels.

Antibiotic Overuse Persists in Community-Acquired Pneumonia

Discordant tests haven’t discouraged antibiotic coverage for methicillin-resistant Staphylococcus aureus.

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Latest News

Physicians can reach thousands through social media, raising questions about professional oversight and the consequences of unverified medical advice online.

Dr George Lundberg writes his ode to primary care — and a warning that we’re letting it die.

Dr Bryant explains that tetanus is not passed between individuals, it is caused by a species of bacteria found in the environment.

Point-of-care ultrasound promises rapid, bedside answers without expensive imaging referrals. But whether primary care is fully embracing the technology is up for debate.

Menopausal hormone therapy is tied to a higher coronary heart disease risk in women with high LDL cholesterol levels on estrogen and medroxyprogesterone acetate but not in those with low LDL levels.

Discordant tests haven’t discouraged antibiotic coverage for methicillin-resistant Staphylococcus aureus.

News All Time

Simple Reminders Boost Lung Cancer Screening Rates

Reminders sent to both primary care doctors and patients may substantially increase adherence to annual lung cancer screening.

Is Measles in Yemen a Threat to the Broader Region?

Yemen now ranks third highest in the world for measles cases, a sign of its collapsing healthcare system.

Eye Doctors Urge Caution Ahead of UK Solar Eclipse

On Wednesday evening, the moon will cover up to 96% of the sun in the UK's deepest eclipse since 1999.

Pediatricians Sidestep Trump CDC Vaccine Guidance

Growing distrust of the CDC has prompted pediatricians and health departments to seek independent vaccine guidance.

Antibody Drug Shows Promise in Refractory Lymphoma

Loncastuximab tesirine shows promise for patients with diffuse large B-cell lymphoma after multiple treatments, including relapse following chimeric antigen receptor T-cell therapy.

When Cost-Saving Software Undermines GP Prescribing

As part of the BMA's collective action, GPs are switching off prescribing prompts that critics say put cost ahead of patient care.

Acalabrutinib May Offer Durable Results in CLL Treatment

Acalabrutinib monotherapy offers sustained progression-free and overall survival in treatment-naive chronic lymphocytic leukemia.

Air Conditioning or Viruses: What’s Causing Summer Colds?

Air conditioning may affect indoor air quality and comfort, but clinicians should focus on viral transmission and heat-related illness when advising patients.

How Financial Toxicity Undermines Patient Trust

Patients hand over their lives in a single meeting. Dr Emil Lou discusses why financial strain is the single biggest threat to that fragile trust.

Ultra-Processed Foods: What Are They and Why Do We Eat Them

Dr Anne Peters discusses tips for how to reduce ultra-processed food consumption with patients.

A Simpler Way to Use Estrogen Cream to Stop Repeat UTIs

For women past menopause, rubbing estrogen cream around the urinary opening may prevent repeat UTIs just as well as inserting it into the vagina with an applicator, with less itch.

Top US Neurology and Neurosurgery Hospitals Ranked

NYU Langone Hospitals in New York City remains the best US hospital for neurology care, says the annual US News & World Report annual ranking of best hospitals for neurology and neurosurgery.

Rome V Updates Diagnosis of Gut-Brain Axis Disorders

The updated Rome V criteria broaden IBS diagnosis and emphasize multidisciplinary care, including diet and psychological support, in chronic digestive disorders.

NICE Expands First-Line Options for Two Blood Cancers

NICE has recommended acalabrutinib combinations for untreated MCL and CLL, including an all-oral option for some patients.

Prenatal Antidepressants Lower Postpartum Depression Risk

Continuing antidepressant medications during pregnancy is associated with lower postpartum depression risk in women with a history of depression.

FDA Okays First-in-Class Narcolepsy Drug Oveporexton

Oveporexton (Orzeyful) is the first drug to target the underlying biological cause of narcolepsy type 1 by directly restoring orexin signaling.

Recommended News For You

CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record

Patient Endured 9 Years of Chemotherapy for Cancer He Never Had

Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer

Who Bears the Cost of "Forever Chemical" Cleanup?

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

Veterans of the Navy have high lung cancer rates associated with asbestos use.

Dietary Intervention Shows Promise in Blood Cancers

Recommended Articles For You

Gut microbiota in curing cancer 

Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer 

Understanding Histiocytosis: Symptoms, Causes, and Treatment Options 

Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

2.

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

3.

In a study, immune detection of oral cancers is linked to obesity.

4.

Mapping lifelong chronic health risks for childhood cancer survivors

5.

FDA approves Blenrep for relapsed or refractory multiple myeloma

1.

The Benefits and Risks of Cervical Conization

2.

Know About Lymphangioma: Symptoms, Causes, and Treatments

3.

Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars

4.

A New Dawn for Triple-Negative Breast Cancer: Emerging Therapies and the Art of Healing

5.

Ferroptosis-Modulating Therapies for Treatment-Resistant Malignancies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

2.

Future of Hematology

3.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

4.

Diagnosis and Management in Hematology

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot